Recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes.

Documenti analoghi

• An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance.
  di: Henricson, B E, et al.
  Pubblicazione: (1991)
• Effects of recombinant human interleukin-6 alone and in combination with recombinant interleukin-1 alpha and tumor necrosis factor alpha on antibacterial resistance in mice.
  di: Czuprynski, C J, et al.
  Pubblicazione: (1992)
• Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression.
  di: Zuckerman, S H, et al.
  Pubblicazione: (1991)
• Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression.
  di: Ulich, T. R., et al.
  Pubblicazione: (1990)
• Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity
  Pubblicazione: (1988)